You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 2 Next »

This project team will create a White Paper with recommendations for analyses and displays associated with hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project Leads:

Melvin Munsakamelvin.munsaka@abbvie.com
Terry Walshterry.walsh@astellas.com
  • No labels